CNS Disease in ALK-Positive NSCLC: Monitoring and Systemic vs. Radiation Therapy episode artwork

EPISODE · Apr 12, 2016 · 2 MIN

CNS Disease in ALK-Positive NSCLC: Monitoring and Systemic vs. Radiation Therapy

from GRACEcast · host cancerGRACE Meetings

Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.

Episode metadata supplied by the publisher feed · Published Apr 12, 2016

Embed this episode

NOW PLAYING

CNS Disease in ALK-Positive NSCLC: Monitoring and Systemic vs. Radiation Therapy

0:00 2:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on April 12, 2016.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!